Meet The Partners

Our partners bring deep experience in biopharmaceutical strategy and leadership

Ron Dunbar leverages >20 years of biopharma industry expertise, having held key commercial roles within emerging to top 50 biopharma companies and, over the past decade, serving as an external advisor to biopharma and B2B clients on commercial strategies.

He specializes in commercial strategy, value maximization, market access, specialty pharmacy distribution and real-world data. Ron supports clients in commercial planning and product launch optimization. Previously, Ron was Principal at Prescription Alliance and VP Market Access at TwoLabs/Envision Pharma Group. His commercial biopharma roles were held at Eurand, UCB, Celltech, Medeva, and Adams Laboratories.

Ron holds a Bachelor of Science in Health from Purdue University.

If you are seeking to increase access-centric commercialization or RWD customer visibility let’s connect.

Samantha John has 27+ years of experience building brands in specialty biopharma, playing key roles in the launch of several blockbuster drugs. She has led marketing, sales, and operations, and has built commercial organizations from the ground up, including ecosystem teams and partnerships while at Aimmune Therapeutics, UCB and Eli Lilly.

She has worked in the US, Canada, and EU, understanding varied payer systems and marketing needs to build brands for optimal results globally. A multiple-time President’s Club winner, Samantha leverages insights to develop strategies that drive commercial success.

Samantha holds a Bachelor of Science from the University of Kentucky.

Jason Moore brings > 18 years of advisory and life sciences industry experience across commercial strategy, portfolio planning, product launch, and corporate development. His expertise spans leading strategic planning, market planning, and M&A in both consulting and industry roles. Jason has advised a diverse range of biopharma clients as Senior Principal at Two Labs / Envision Pharma Group and led the San Francisco practice for Navigant Life Sciences (now Guidehouse). Previously, he advanced corporate strategy and commercial growth while holding senior roles at Genentech, Eisai, and Suros Surgical Systems (now Hologic).

Known for his analytical rigor, Jason helps life sciences companies with strategic planning, market growth, and corporate development. He supports clients in commercial planning, product launches, and M&A, using strategic insights to drive results. Jason leads projects in portfolio strategy and business development, working with clients to tackle challenges, optimize assets, and enhance decision-making across therapeutic areas.

Jason holds an MBA from Indiana University’s Kelley School of Business, a BA in Molecular Biology from the College of Wooster and studied Biomedical Sciences at Rutgers (formerly UMDNJ).